Table 1.
Thyroid function and cortisol levels post discharge.
Day post durvalumab commencement | Reference range | ||||||
---|---|---|---|---|---|---|---|
Day 56 | Day 101 | Day 119 | Day 127 | Day 133 | Day 161 | ||
TSH (mIU/L) | 0.41 | 4.35 | 6.39 | 8.69 | 11.8 | 6.29 | 0.40–4.80 |
FreeT4 (pmol/L) | 11.3 | 8.6 | 5.9 | 7.9 | 7.1 | 9.5 | 8.0–16.0 |
TG antibody (IU/mL) | 64 | 0–115 | |||||
TPO antibody (IU/mL) | 2 | 0–10 | |||||
AM cortisol (nmol/L) | 166 | 234 | 339 | 267 | |||
Time | 10:32 h | 10:57 h | 08:10 h | 08:55 h | |||
ACTH (pmol/L) | 2.1 | 0–12 |
ACTH, adrenocorticotropic hormone; TG, thyroglobulin; TPO, thyroid peroxidase; TSH, thyroid-stimulating hormone.